Cargando…
Benchmarking B-Cell Epitope Prediction with Quantitative Dose-Response Data on Antipeptide Antibodies: Towards Novel Pharmaceutical Product Development
B-cell epitope prediction can enable novel pharmaceutical product development. However, a mechanistically framed consensus has yet to emerge on benchmarking such prediction, thus presenting an opportunity to establish standards of practice that circumvent epistemic inconsistencies of casting the epi...
Autor principal: | Caoili, Salvador Eugenio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037609/ https://www.ncbi.nlm.nih.gov/pubmed/24949474 http://dx.doi.org/10.1155/2014/867905 |
Ejemplares similares
-
On the Meaning of Affinity Limits in B-Cell Epitope Prediction for Antipeptide Antibody-Mediated Immunity
por: Caoili, Salvador Eugenio C.
Publicado: (2012) -
Benchmarking B-Cell Epitope Prediction for the Design of Peptide-Based Vaccines: Problems and Prospects
por: Caoili, Salvador Eugenio C.
Publicado: (2010) -
Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
por: Caoili, Salvador Eugenio C.
Publicado: (2013) -
Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics
por: Caoili, Salvador Eugenio C.
Publicado: (2022) -
Properties of the desmin tail domain: studies using synthetic peptides and antipeptide antibodies
Publicado: (1990)